Robin Patel, M.D., Appointed Member of New National Institute for Antimicrobial Resistance Research and Education
Robin Patel, M.D., Chair of the Division of Clinical Microbiology, has been appointed as a founding member of the new Institute for Antimicrobial Resistance Research and Education.
This week’s Research Roundup highlights how fasting blood glucose levels provide an estimate of duration and progression of pancreatic cancer before diagnosis.
Genetic testing is like security-camera video footage of a break-in, providing essential clues to identify a culprit. In certain cancers, the "culprit" might be a rearrangement in a person's DNA, which genomic testing can capture. Mayo Clinic has developed a novel group of clinical tests that zoom in on a person's genome to characterize chromosomal rearrangements.
Mayo Medical Laboratories, National Decision Support Company Team up to Develop Careselect™ Blood, a Comprehensive Approach to Patient Blood Management
Mayo Clinic implemented a patient blood-management program in 2010 on its Rochester campus and has since experienced a 35-percent reduction of blood transfusions, improving patient outcomes and achieving significant savings. Using best practices from the program, Mayo Medical Laboratories collaborated with National Decision Support Company (NDSC) to combine Mayo’s clinical knowledge with NDSC’s industry-leading expertise in electronic health record clinical-decision support.
Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Laboratory Medicine and Pathology, answers questions about the rat lungworm.
Top highlights this week include: scientists race to improve living drugs to fight cancer, CDC monitoring measles outbreak in 21 states, many breast cancer survivors do not receive recommended mammograms, troubling rise in pregnancy-related heart problems, and Mayo Clinic ranked no. 1 hospital nationwide by U.S. News & World Report.